82497-132-01 : NDC 2026 Code

82497-132-01 : Eflapegrastim-xnst ( Rolvedon )

Additionally :

You can get information about “82497-132-01” NDC code in 82497-132-01 in HTML format

HTML | 82497-132-01 in TXT (Plain Text) format

TXT | 82497-132-01 in PDF (Portable Document Format)

PDF | 82497-132-01 in XML format

XML formats.

NDC Code : 82497-132-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "82497-132-01",
    "PackageDescription": ".6 mL in 1 SYRINGE, GLASS (82497-132-01) ",
    "NDC11Code": "82497-0132-01",
    "ProductNDC": "82497-132",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Rolvedon",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Eflapegrastim-xnst",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "SUBCUTANEOUS",
    "StartMarketingDate": "20251211",
    "EndMarketingDate": null,
    "MarketingCategoryName": "BLA",
    "ApplicationNumber": "BLA761148",
    "LabelerName": "Assertio Specialty Pharmaceuticals, LLC",
    "SubstanceName": "EFLAPEGRASTIM",
    "StrengthNumber": "13.2",
    "StrengthUnit": "mg/.6mL",
    "Pharm_Classes": "Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-12-16",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20251211",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}